FDA Inspection
Boston IVF at The Women's HospitalBoston IVF at The Women's Hospital – FDA Inspection, Apr 5, 2022
Record Details
This FDA Inspection record concerns Boston IVF at The Women's Hospital, with an inspection on April 5, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- April 5, 2022
- Product Type
- Biologics
View Company Profile
ID · ac73a5a3-6bed-4917-be10-228709ce8194
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1168585
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of Boston IVF at The Women's Hospital
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 9, 2025 | VAI | Detroit District Office | Human Cellular, Tissue, and Gene Therapies |
| August 9, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 14, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 6, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Boston IVF at The Women's Hospital
- FDA Inspection 1280953 - 2025-09-09
- FDA Inspection 1021251 - 2017-08-09
- FDA Inspection 936272 - 2015-07-14
- FDA Inspection 830516 - 2013-05-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.